Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale N Gerding

Showing results (81-90 of 199) with videos related to

Pageof 20
Sort By:
Antimicrobial Agents and Chemotherapy|August 17, 2011
Comparative susceptibilities to fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two phase III trials of fidaxomicin against Clostridium difficile infectionEllie J C Goldstein, Diane M Citron, Pamela Sears, et al.
The Pediatric Infectious Disease Journal|October 31, 2015
Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing DecisionsLarry K Kociolek, Sameer J Patel, Xiaotian Zheng, et al.
Journal of Clinical Microbiology|April 19, 2003
International typing study of toxin A-negative, toxin B-positive Clostridium difficile variantsStuart Johnson, Susan P Sambol, Jon S Brazier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2018
Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center AnalysisLarry K Kociolek, Dale N Gerding, Robyn O Espinosa, et al.
Journal of Bacteriology|August 3, 2010
Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin productionMichelle Merrigan, Anilrudh Venugopal, Michael Mallozzi, et al.
The Journal of Antimicrobial Chemotherapy|January 18, 2018
Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospitalLarry K Kociolek, Egon A Ozer, Dale N Gerding, et al.
Genome Announcements|September 23, 2017
Complete Genome Sequence of <i>Clostridioides difficile</i> Epidemic Strain DH/NAP11/106/ST-42, Isolated from Stool from a Pediatric Patient with DiarrheaEgon A Ozer, Alan R Hauser, Dale N Gerding, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2015
Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027Jeffrey T Wieczorkiewicz, Bert K Lopansri, Adam Cheknis, et al.
The Journal of Infectious Diseases|November 30, 2011
Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonizationFarida Siddiqui, Jennifer R O'Connor, Kristin Nagaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2010
Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United KingdomVhairi Wilson, Liz Cheek, Giovanni Satta, et al.
Pageof 20

Showing results (81-90 of 199) with videos related to

Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|August 17, 2011
Comparative susceptibilities to fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two phase III trials of fidaxomicin against Clostridium difficile infectionEllie J C Goldstein, Diane M Citron, Pamela Sears, et al.
The Pediatric Infectious Disease Journal|October 31, 2015
Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing DecisionsLarry K Kociolek, Sameer J Patel, Xiaotian Zheng, et al.
Journal of Clinical Microbiology|April 19, 2003
International typing study of toxin A-negative, toxin B-positive Clostridium difficile variantsStuart Johnson, Susan P Sambol, Jon S Brazier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2018
Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center AnalysisLarry K Kociolek, Dale N Gerding, Robyn O Espinosa, et al.
Journal of Bacteriology|August 3, 2010
Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin productionMichelle Merrigan, Anilrudh Venugopal, Michael Mallozzi, et al.
The Journal of Antimicrobial Chemotherapy|January 18, 2018
Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospitalLarry K Kociolek, Egon A Ozer, Dale N Gerding, et al.
Genome Announcements|September 23, 2017
Complete Genome Sequence of <i>Clostridioides difficile</i> Epidemic Strain DH/NAP11/106/ST-42, Isolated from Stool from a Pediatric Patient with DiarrheaEgon A Ozer, Alan R Hauser, Dale N Gerding, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2015
Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027Jeffrey T Wieczorkiewicz, Bert K Lopansri, Adam Cheknis, et al.
The Journal of Infectious Diseases|November 30, 2011
Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonizationFarida Siddiqui, Jennifer R O'Connor, Kristin Nagaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2010
Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United KingdomVhairi Wilson, Liz Cheek, Giovanni Satta, et al.
Pageof 20